Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic Efficacy in Third Molar Surgery
NCT00118820Phase 3Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Mar 2004
- Primary completion
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Benzathine penicillin and clindamycin in alveolar osteitis (AO) and surgical site infection (SSI) (2 arms), sponsored by Massachusetts General Hospital. Primary endpoint: Presence or absence of postoperative inflammatory complication: i.e., alveolar osteitis or infection. Started Mar 2004; status: completed.
02
Drugs
Benzathine penicillinclindamycin
03
Conditions
alveolar osteitis (AO)surgical site infection (SSI)
Beyond the preview
Go deeper on NCT00118820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00118820.